Nitro-dur and Atelectasis - a phase IV clinical study of FDA data

Summary:

Atelectasis is reported as a side effect among people who take Nitro-dur (nitroglycerin), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Lasix, and have Asthma.

The phase IV clinical study analyzes which people have Atelectasis when taking Nitro-dur. It is created by eHealthMe based on reports of 2,383 people who have side effects when taking Nitro-dur from the FDA, and is updated regularly.

What is Nitro-dur?

Nitro-dur has active ingredients of nitroglycerin. eHealthMe is studying from 2,414 Nitro-dur users. Check the latest studies of Nitro-dur.

What is Atelectasis?

Atelectasis (partial or complete collapse of the lung) is found to be associated with 1,438 drugs and 1,637 conditions by eHealthMe. Check the latest studies of Atelectasis.

On Aug, 12, 2026

2,383 people reported to have side effects when taking Nitro-dur.
Among them, 18 people (0.76%) have Atelectasis.

Among these 18 people:

How long have people been on Nitro-dur when they have Atelectasis? *

What is the gender of people who have Atelectasis when taking Nitro-dur? *

female: 58.82 %
male: 41.18 %

What is the age of people who have Atelectasis when taking Nitro-dur? *

What are other drugs people take besides Nitro-dur? *

What are other side effects people have besides Atelectasis? *

Rales (an abnormal respiratory sound characterized by fine crackles): 12 people, 66.67%
Wheezing (a high-pitched whistling sound made while you breath): 11 people, 61.11%
Pleural Effusion (water on the lungs): 10 people, 55.56%
Dyspnea (difficult or laboured breathing): 8 people, 44.44%
Weight Increased: 7 people, 38.89%
Enlarged Heart: 7 people, 38.89%
Cardiac Failure Congestive: 7 people, 38.89%
Chest Pain: 6 people, 33.33%
Sputum Increased: 6 people, 33.33%
Dizziness: 6 people, 33.33%

What are the existing conditions these people have? *

Asthma: 6 people, 33.33%
Stable Angina (a constant chest pain): 3 people, 16.67%
Multiple Myeloma (cancer of the plasma cells): 3 people, 16.67%
Depression: 3 people, 16.67%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 16.67%
Arrhythmias (irregular heartbeat): 3 people, 16.67%
Vasculitis (inflammation of a blood vessel or blood vessels): 2 people, 11.11%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 2 people, 11.11%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 11.11%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Nitro-dur and have Atelectasis?

- Check whether Atelectasis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitro-dur:

Nitro-dur (2,414 reports)

Atelectasis treatments and more:

Atelectasis (17,087 reports)

Browse all side effects of Nitro-dur:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atelectasis:

Atelectasis (1,438 drugs)

Browse all the conditions that are associated with Atelectasis:

Atelectasis (1,637 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitroglycerin (the active ingredients of Nitro-dur) and Nitro-dur (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.